Svenja Kaczorowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Svenja Kaczorowski has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Ludovic Belavy
Fachbereich Pflege-, Hebammen- und Therapiewissenschaften (PHT), Hochschule Bochum, Bochum, Germany
9 shared publications - Patrick J. Owen
Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
9 shared publications - Tobias Saueressig
Physio Meets Science GmbH, Leimen, Germany
8 shared publications - Clint Thomas Miller
Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia
6 shared publications - Lars Donath
Department of Applied Exercise Science, German Sport University Cologne, Cologne, Germany
6 shared publications - Hugo Pedder
Bristol Medical School, University of Bristol, Bristol, UK
5 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1) , 851
Digital and hybrid interventions for subacute and chronic low back pain: component network meta-analysis
Digital and hybrid interventions combining exercise, education, and psychological components are increasingly used for low back pain (LBP), but it remains unclear which components and combinations drive efficacy. We conducted a prospectively registered component network meta-analysis (CNMA) to evaluate their efficacy and safety for non-specific LBP. Six databases and two trial registries were searched to May 2025. Data on disability, pain intensity, and adverse events were analysed using a Bayesian random-effects CNMA. Of 2809 records, 56 reports of 46 studies (6717 participants; 80% chronic low back pain) were included. Hybrid interventions combining digital and in-person exercise with in-person psychological components (MD: –22.21; 95%-CrI: –34.11 to –10.67), digital and in-person exercise (MD: –15.75; 95%-CrI: –22.79 to –8.80), or digital exercise with physiotherapy (MD: –13.17; 95%-CrI: –21.18 to –5.16) reduced disability versus no intervention at short-term (minimal clinically important difference (MCID): 4.92/100 Oswestry Disability Index). Digital and in-person exercise (MD: -1.76; 95%-CrI: -2.62; -0.87) and combined digital exercise training with in-person education (MD: -1.73; 95%-CrI: -2.71; -0.83) improved pain intensity beyond the MCID (0.82/10 numeric pain rating scale). No serious adverse events were noted. Multicomponent hybrid interventions appear safe and may provide clinically meaningful improvements for chronic LBP.
- 4 November 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1) , 851
Open AccessDigital and hybrid interventions for subacute and chronic low back pain: component network meta-analysis
Digital and hybrid interventions combining exercise, education, and psychological components are increasingly used for low back pain (LBP), but it remains unclear which components and combinations drive efficacy. We conducted a prospectively registered component network meta-analysis (CNMA) to evaluate their efficacy and safety for non-specific LBP. Six databases and two trial registries were searched to May 2025. Data on disability, pain intensity, and adverse events were analysed using a Bayesian random-effects CNMA. Of 2809 records, 56 reports of 46 studies (6717 participants; 80% chronic low back pain) were included. Hybrid interventions combining digital and in-person exercise with in-person psychological components (MD: –22.21; 95%-CrI: –34.11 to –10.67), digital and in-person exercise (MD: –15.75; 95%-CrI: –22.79 to –8.80), or digital exercise with physiotherapy (MD: –13.17; 95%-CrI: –21.18 to –5.16) reduced disability versus no intervention at short-term (minimal clinically important difference (MCID): 4.92/100 Oswestry Disability Index). Digital and in-person exercise (MD: -1.76; 95%-CrI: -2.62; -0.87) and combined digital exercise training with in-person education (MD: -1.73; 95%-CrI: -2.71; -0.83) improved pain intensity beyond the MCID (0.82/10 numeric pain rating scale). No serious adverse events were noted. Multicomponent hybrid interventions appear safe and may provide clinically meaningful improvements for chronic LBP.
- Open Access
- 24 September 2026
- Published by BMJ in British Journal of Sports Medicine
Optimal exercise dose in adults with chronic low back pain disorders: systematic review with dose-response network meta-analysis
Objective: To quantify exercise dose-response relationships and estimate the optimal dose in adults with chronic low back pain disorders (CLBDs). Design: Systematic review with random-effects model-based (non-linear) dose-response network meta-analysis. Risk of bias was assessed with Cochrane RoB 2 and certainty with the minimally contextualised Grading of Recommendations, Assessment, Development and Evaluation framework. A ≥5-point change (scaled 0–100) was predefined as clinically meaningful. Data sources: Six databases, two trial registries and citations were searched to 3 June 2025 Eligibility criteria: Randomised controlled trials of exercise in adults (≥18 years) with CLBDs assessing disability or back pain at short (>1 day and ≤3 months), intermediate (>3 months and<12 months) and long-term (≥12 months) follow-up. Results: We included 239 trials (252 reports); 99.2% included non-specific chronic low back pain; two trials included radicular presentations. The model-predicted optimal dose for short-term disability was 4 sessions/week, 25 min/session over 13 weeks. For short-term pain intensity, the optimal dose was 3 sessions/week, 30 min/session over 8 weeks. However, credible intervals of most dose-levels overlapped. Few dose combinations were clinically meaningful beyond the short term. 84% of trials were at high risk of bias and certainty was very low to low. Adverse events (reported in 28.5% of trials) were predominantly non-serious and musculoskeletal. Conclusions: Exercise training delivered at low to moderate doses was associated with short-term improvements in disability and pain intensity, which may be clinically meaningful, with limited additional benefit at higher exposure. Model-predicted doses provide guidance for exercise prescription; but the available evidence does not support a single optimal exercise dose and should be interpreted with caution given the low to very low certainty of evidence. Exercise training for radicular presentations is a key evidence gap.
- 24 September 2026
- Published by BMJ in British Journal of Sports Medicine
Open AccessOptimal exercise dose in adults with chronic low back pain disorders: systematic review with dose-response network meta-analysis
Objective: To quantify exercise dose-response relationships and estimate the optimal dose in adults with chronic low back pain disorders (CLBDs). Design: Systematic review with random-effects model-based (non-linear) dose-response network meta-analysis. Risk of bias was assessed with Cochrane RoB 2 and certainty with the minimally contextualised Grading of Recommendations, Assessment, Development and Evaluation framework. A ≥5-point change (scaled 0–100) was predefined as clinically meaningful. Data sources: Six databases, two trial registries and citations were searched to 3 June 2025 Eligibility criteria: Randomised controlled trials of exercise in adults (≥18 years) with CLBDs assessing disability or back pain at short (>1 day and ≤3 months), intermediate (>3 months and<12 months) and long-term (≥12 months) follow-up. Results: We included 239 trials (252 reports); 99.2% included non-specific chronic low back pain; two trials included radicular presentations. The model-predicted optimal dose for short-term disability was 4 sessions/week, 25 min/session over 13 weeks. For short-term pain intensity, the optimal dose was 3 sessions/week, 30 min/session over 8 weeks. However, credible intervals of most dose-levels overlapped. Few dose combinations were clinically meaningful beyond the short term. 84% of trials were at high risk of bias and certainty was very low to low. Adverse events (reported in 28.5% of trials) were predominantly non-serious and musculoskeletal. Conclusions: Exercise training delivered at low to moderate doses was associated with short-term improvements in disability and pain intensity, which may be clinically meaningful, with limited additional benefit at higher exposure. Model-predicted doses provide guidance for exercise prescription; but the available evidence does not support a single optimal exercise dose and should be interpreted with caution given the low to very low certainty of evidence. Exercise training for radicular presentations is a key evidence gap.
- Open Access
- 30 June 2026
- Published by BMJ in BMJ Medicine
- Vol. 5 (1) , e001908
Conservative treatments for chronic non-specific low back pain: time course network meta-analysis
Objective: To examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain. Design: Time course network meta-analysis. Data sources: Six electronic databases (Medline, SPORTDiscus, CINAHL, PsycINFO, Embase, and CENTRAL), searched from inception to 24 July 2020, and 302 previous systematic reviews. Eligibility criteria for selecting studies: Full peer reviewed publications in English or German of randomised controlled trials, randomised clinical trials, randomised controlled cluster trials, or randomised crossover trials in adults (aged ≥18 years) receiving common conservative treatments for non-specific and radicular chronic low back pain. Treatments examined were acupuncture, education or advice, electrotherapy (including heat and ice electrotherapeutic modalities applied non-invasively), exercise training, manual treatments or manipulation, massage, the McKenzie method, pharmacotherapy, psychological treatments, traction, physical therapy (otherwise not falling into specific treatment combinations), placebo, multidisciplinary pain management, usual care (eg, management by a doctor), and no treatment (true control). Results: Back pain intensity, leg pain intensity, disability, and mental health outcomes were reported immediately (3 and <12 months), and long term (≥12 months) time points. 581 reports of 551 studies (71 126 patients) were included. 510 trials included people with non-specific chronic low back pain and 41 trials included those with radicular chronic low back pain. For back pain (0-100 scale), acupuncture (mean difference −20.91, 95% credible interval −24.00 to −11.95), electrotherapy (−18.98, −21.84 to−10.95), exercise (−15.59, −17.51 to −10.05), manual treatment (−19.48, −22.17 to −11.74), massage (−25.61, −30.42 to −10.91), and multidisciplinary pain management (−18.96, −22.26 to −9.58) exceeded the minimal clinically important difference (set at 0.5 standard deviation) in the short term. For disability (0-100 scale), acupuncture (mean difference −10.52, 95% credible intervals −11.84 to −6.59), massage (−9.95, −11.45 to −5.50), and multidisciplinary pain management (−12.56, −13.91 to −8.55) were clinically effective in the short term. In the immediate and intermediate term only, the McKenzie method and massage, respectively, exceeded the minimal clinically important difference. In the long term, although two of the 14 treatments for back pain and nine of 14 treatments for disability had statistically significant benefits compared with no treatment, the effects were not clinically significant. The certainty of the evidence based on the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was low (1.4%) to very low (98.6%) across interventions and time points. Findings for massage and the McKenzie method were not stable in the sensitivity analyses. Treatment effects for radicular chronic low back pain did not seem to differ from those for non-specific chronic low back pain. Conclusions: Some treatments were effective for pain and function in non-specific chronic low back pain, but improvements did not persist long term. Most of the evidence was for non-specific chronic low back pain; the evidence base for radicular chronic low back pain was limited. Although sensitivity analyses did not provide evidence for a different response in radicular chronic low back pain, an evidence gap remains for this subpopulation. Future work should explore strategies to establish the long term efficacy of modifications to lifestyle and behaviour. Systematic review registration: PROSPERO CRD42020182039
- 30 June 2026
- Published by BMJ in BMJ Medicine
- Vol. 5 (1) , e001908
Open AccessConservative treatments for chronic non-specific low back pain: time course network meta-analysis
Objective: To examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain. Design: Time course network meta-analysis. Data sources: Six electronic databases (Medline, SPORTDiscus, CINAHL, PsycINFO, Embase, and CENTRAL), searched from inception to 24 July 2020, and 302 previous systematic reviews. Eligibility criteria for selecting studies: Full peer reviewed publications in English or German of randomised controlled trials, randomised clinical trials, randomised controlled cluster trials, or randomised crossover trials in adults (aged ≥18 years) receiving common conservative treatments for non-specific and radicular chronic low back pain. Treatments examined were acupuncture, education or advice, electrotherapy (including heat and ice electrotherapeutic modalities applied non-invasively), exercise training, manual treatments or manipulation, massage, the McKenzie method, pharmacotherapy, psychological treatments, traction, physical therapy (otherwise not falling into specific treatment combinations), placebo, multidisciplinary pain management, usual care (eg, management by a doctor), and no treatment (true control). Results: Back pain intensity, leg pain intensity, disability, and mental health outcomes were reported immediately (3 and <12 months), and long term (≥12 months) time points. 581 reports of 551 studies (71 126 patients) were included. 510 trials included people with non-specific chronic low back pain and 41 trials included those with radicular chronic low back pain. For back pain (0-100 scale), acupuncture (mean difference −20.91, 95% credible interval −24.00 to −11.95), electrotherapy (−18.98, −21.84 to−10.95), exercise (−15.59, −17.51 to −10.05), manual treatment (−19.48, −22.17 to −11.74), massage (−25.61, −30.42 to −10.91), and multidisciplinary pain management (−18.96, −22.26 to −9.58) exceeded the minimal clinically important difference (set at 0.5 standard deviation) in the short term. For disability (0-100 scale), acupuncture (mean difference −10.52, 95% credible intervals −11.84 to −6.59), massage (−9.95, −11.45 to −5.50), and multidisciplinary pain management (−12.56, −13.91 to −8.55) were clinically effective in the short term. In the immediate and intermediate term only, the McKenzie method and massage, respectively, exceeded the minimal clinically important difference. In the long term, although two of the 14 treatments for back pain and nine of 14 treatments for disability had statistically significant benefits compared with no treatment, the effects were not clinically significant. The certainty of the evidence based on the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was low (1.4%) to very low (98.6%) across interventions and time points. Findings for massage and the McKenzie method were not stable in the sensitivity analyses. Treatment effects for radicular chronic low back pain did not seem to differ from those for non-specific chronic low back pain. Conclusions: Some treatments were effective for pain and function in non-specific chronic low back pain, but improvements did not persist long term. Most of the evidence was for non-specific chronic low back pain; the evidence base for radicular chronic low back pain was limited. Although sensitivity analyses did not provide evidence for a different response in radicular chronic low back pain, an evidence gap remains for this subpopulation. Future work should explore strategies to establish the long term efficacy of modifications to lifestyle and behaviour. Systematic review registration: PROSPERO CRD42020182039
- Open Access
- 25 August 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e59866
Usability and Acceptability of an App-Based Approach to Treat Low Back Pain: Preplanned Secondary Analysis of a Randomized Controlled Trial
Background: Low back pain (LBP) is a major cause of disability worldwide. To tackle issues such as long wait times and limited access to conventional care, telemedicine is emerging as a viable alternative. It offers benefits such as reduced travel and increased flexibility, with evidence showing comparable effectiveness to in-person care. However, usability remains a key challenge, impacting patient compliance. Objectives: In a 3-arm randomized controlled trial, our preplanned secondary analysis aimed to assess the usability and patient perceptions toward an autonomous app-based intervention (“NOLA”) for LBP to improve clinical practice of telemedicine interventions. Objectives included evaluating app usability, assessing perceptions toward telemedicine, and exploring app usage, adherence, and motivation. Methods: Patients with LBP were recruited from May to August 2022 and randomized into App, Physio+App, or Physio groups. App and Physio+App groups were included in this subanalysis. Intervention duration was 6 weeks. Data on baseline characteristics, System Usability Scale, Telemedicine Perception Questionnaire, app usage, adherence, and motivation were collected via web-based questionnaires. Results: A total of 64 participants were randomized to use the app with available data for 38 participants. The mean age of participants who completed was 49.9 (SD 13.6) years, with 78% (29/38) experiencing LBP for more than 2 years. Usability scores (0‐100) were good (Physio+App: median 78, IQR 58-92, app: median 86, IQR 65-91). Positive telemedicine perceptions were noted, with 84% (15/20) rating it an adequate addition to usual care. App usage varied, with 43% (16/35) using it 3 to 5 days per week, and 64% (21/33) reported motivation to use the app. The dropout rates (App: 14/32, 44%; Physio+App: 12/32, 38%; Physio: 11/29, 38%) were similar, but participants who dropped out had statistically significantly less pain (completers: mean 3.9, SD 2.0; dropouts: mean 3.0, SD 2.0; P=.02). Reasons for dropout were mostly not reported. Conclusions: The app “NOLA” demonstrated good usability, and participants expressed positive perceptions toward telemedicine in those who completed the intervention. Despite concerns about the lack of physical contact, the majority considered telemedicine a convenient form of health care delivery. App usage and motivation were favorable, emphasizing the potential of app-based interventions in managing LBP.
- 25 August 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e59866
Open AccessUsability and Acceptability of an App-Based Approach to Treat Low Back Pain: Preplanned Secondary Analysis of a Randomized Controlled Trial
Background: Low back pain (LBP) is a major cause of disability worldwide. To tackle issues such as long wait times and limited access to conventional care, telemedicine is emerging as a viable alternative. It offers benefits such as reduced travel and increased flexibility, with evidence showing comparable effectiveness to in-person care. However, usability remains a key challenge, impacting patient compliance. Objectives: In a 3-arm randomized controlled trial, our preplanned secondary analysis aimed to assess the usability and patient perceptions toward an autonomous app-based intervention (“NOLA”) for LBP to improve clinical practice of telemedicine interventions. Objectives included evaluating app usability, assessing perceptions toward telemedicine, and exploring app usage, adherence, and motivation. Methods: Patients with LBP were recruited from May to August 2022 and randomized into App, Physio+App, or Physio groups. App and Physio+App groups were included in this subanalysis. Intervention duration was 6 weeks. Data on baseline characteristics, System Usability Scale, Telemedicine Perception Questionnaire, app usage, adherence, and motivation were collected via web-based questionnaires. Results: A total of 64 participants were randomized to use the app with available data for 38 participants. The mean age of participants who completed was 49.9 (SD 13.6) years, with 78% (29/38) experiencing LBP for more than 2 years. Usability scores (0‐100) were good (Physio+App: median 78, IQR 58-92, app: median 86, IQR 65-91). Positive telemedicine perceptions were noted, with 84% (15/20) rating it an adequate addition to usual care. App usage varied, with 43% (16/35) using it 3 to 5 days per week, and 64% (21/33) reported motivation to use the app. The dropout rates (App: 14/32, 44%; Physio+App: 12/32, 38%; Physio: 11/29, 38%) were similar, but participants who dropped out had statistically significantly less pain (completers: mean 3.9, SD 2.0; dropouts: mean 3.0, SD 2.0; P=.02). Reasons for dropout were mostly not reported. Conclusions: The app “NOLA” demonstrated good usability, and participants expressed positive perceptions toward telemedicine in those who completed the intervention. Despite concerns about the lack of physical contact, the majority considered telemedicine a convenient form of health care delivery. App usage and motivation were favorable, emphasizing the potential of app-based interventions in managing LBP.
- Open Access
- 22 December 2024
- Published by BMJ in BMJ Open Sport & Exercise Medicine
- Vol. 10 (4) , e002262
How to conduct and report checking transitivity and inconsistency in network-meta-analysis: a narrative review including practical worked examples, code and source data for sports and exercise medicine researchers
The use of network meta-analysis (NMA) in sport and exercise medicine (SEM) research continues to rise as it enables the comparison of multiple interventions that may not have been assessed in a single randomised controlled trial. NMA can then inform clinicians on potentially better interventions. Despite the increased use of NMA, we have observed that in the SEM field, a key challenge for author groups can be the assessment and reporting of key assumptions, in particular transitivity and consistency. This paper provides SEM researchers with a practical guide on how to approach the transitivity and consistency assumptions of NMA. Using a previously published NMA in the SEM field, we provide the statistical code, source data and worked examples to facilitate understanding and best practice of NMA in the particular field. We hope these resources result in improved conduct and reporting of NMA that ultimately leads to advances in the SEM field.
- 22 December 2024
- Published by BMJ in BMJ Open Sport & Exercise Medicine
- Vol. 10 (4) , e002262
Open AccessHow to conduct and report checking transitivity and inconsistency in network-meta-analysis: a narrative review including practical worked examples, code and source data for sports and exercise medicine researchers
The use of network meta-analysis (NMA) in sport and exercise medicine (SEM) research continues to rise as it enables the comparison of multiple interventions that may not have been assessed in a single randomised controlled trial. NMA can then inform clinicians on potentially better interventions. Despite the increased use of NMA, we have observed that in the SEM field, a key challenge for author groups can be the assessment and reporting of key assumptions, in particular transitivity and consistency. This paper provides SEM researchers with a practical guide on how to approach the transitivity and consistency assumptions of NMA. Using a previously published NMA in the SEM field, we provide the statistical code, source data and worked examples to facilitate understanding and best practice of NMA in the particular field. We hope these resources result in improved conduct and reporting of NMA that ultimately leads to advances in the SEM field.
- 28 November 2024
- Published by Elsevier in The Journal of Pain
- Vol. 29, 104745
Are some people more susceptible to placebos? A systematic review and meta-analysis of inter-individual variability in musculoskeletal pain
- 28 November 2024
- Published by Elsevier in The Journal of Pain
- Vol. 29, 104745
Are some people more susceptible to placebos? A systematic review and meta-analysis of inter-individual variability in musculoskeletal pain
- Open Access
- 16 August 2024
- Published by BMJ in BMJ Open Sport & Exercise Medicine
- Vol. 10 (3) , e002108-9
DOSage of Exercise for chronic low back pain disorders (DOSE): protocol for a systematic review with dose-response network meta-analysis
Chronic low back disorders are the leading cause of direct and indirect healthcare burden globally. Exercise training improves pain intensity, mental health and physical function. However, the optimal prescription variables are unknown. We aim to compare the efficacy of various exercise dosages for chronic low back disorders to identify the optimal prescription variables. Six databases (Medline, SPORTDiscus, CINAHL, PsycINFO, EMBASE and CENTRAL), trial registries (ClinicalTrials.gov and WHO International Clinical Trials Registry Platform) and reference lists of prior systematic reviews will be searched, and we will conduct forward and backward citation tracking. We will include peer-reviewed randomised controlled trials (individual, cluster or cross-over trials) published in English or German language comparing exercise training to other exercise training or non-exercise training interventions (conservative, non-surgical, non-pharmacological, non-invasive treatments, placebo, sham, usual/standard care, no-treatment control, waitlist control) in adults with chronic low back disorders. Outcomes will include pain intensity, disability, mental health, adverse events, adherence rate, dropout rate and work capacity. Version 2 of the Cochrane risk-of-bias tool will be employed. The dose will be categorised as cumulative dose (total and weekly minutes of exercise training) and individual dose prescription variables (intervention duration, session duration, frequency and intensity). Dose-response model-based network meta-analysis will be used to assess the comparative efficacy of different exercise doses to determine a dose–response relationship. The certainty of evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation. Information about optimal exercise training dosage will help in enhancing treatment outcomes.
- 16 August 2024
- Published by BMJ in BMJ Open Sport & Exercise Medicine
- Vol. 10 (3) , e002108-9
Open AccessDOSage of Exercise for chronic low back pain disorders (DOSE): protocol for a systematic review with dose-response network meta-analysis
Chronic low back disorders are the leading cause of direct and indirect healthcare burden globally. Exercise training improves pain intensity, mental health and physical function. However, the optimal prescription variables are unknown. We aim to compare the efficacy of various exercise dosages for chronic low back disorders to identify the optimal prescription variables. Six databases (Medline, SPORTDiscus, CINAHL, PsycINFO, EMBASE and CENTRAL), trial registries (ClinicalTrials.gov and WHO International Clinical Trials Registry Platform) and reference lists of prior systematic reviews will be searched, and we will conduct forward and backward citation tracking. We will include peer-reviewed randomised controlled trials (individual, cluster or cross-over trials) published in English or German language comparing exercise training to other exercise training or non-exercise training interventions (conservative, non-surgical, non-pharmacological, non-invasive treatments, placebo, sham, usual/standard care, no-treatment control, waitlist control) in adults with chronic low back disorders. Outcomes will include pain intensity, disability, mental health, adverse events, adherence rate, dropout rate and work capacity. Version 2 of the Cochrane risk-of-bias tool will be employed. The dose will be categorised as cumulative dose (total and weekly minutes of exercise training) and individual dose prescription variables (intervention duration, session duration, frequency and intensity). Dose-response model-based network meta-analysis will be used to assess the comparative efficacy of different exercise doses to determine a dose–response relationship. The certainty of evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation. Information about optimal exercise training dosage will help in enhancing treatment outcomes.
- Open Access
- 2 May 2024
- Published by SAGE Publications in Telemedicine and e-Health
- Vol. 30 (5) , 1221-1238
Telemedicine for Patients with Musculoskeletal Pain Lacks High-Quality Evidence on Delivery Modes and Effectiveness: An Umbrella Review
Background: Musculoskeletal (MSK) pain is the leading cause of disability worldwide. Telemedicine is of growing importance, yet impacts on treatment efficacy remain unclear. Objective: This umbrella review (CRD42022298047) examined the effectiveness of telemedicine interventions on pain intensity, disability, psychological function, quality of life, self-efficacy, and adverse events in MSK pain. Methods: PubMed, SPORTDiscus, Cochrane Library, EMBASE, and CINAHL were searched from inception to August 9, 2022, for systematic reviews with meta-analysis, including telemedicine-delivered exercise, education, and psychological interventions, in randomized controlled trials (RCTs). AMSTAR-2 was implemented. Standardized mean differences (SMDs; negative favors telemedicine) were extracted as effect estimates. Results: Of 1,135 records, 20 reviews (RCTs: n = 97, participants: n = 15,872) were included. Pain intensity SMDs were −0.66 to 0.10 for mixed pain (estimates: n = 16), −0.64 to −0.01 for low-back pain (n = 9), −0.31 to −0.15 for osteoarthritis (n = 7), −0.29 for knee pain (n = 1), −0.66 to −0.58 for fibromyalgia (n = 2), −0.16 for back pain (n = 1), and −0.09 for rheumatic disorders (n = 1). Disability SMDs were −0.50 to 0.10 for mixed pain (n = 14), −0.39 to 0.00 for low-back pain (n = 8), −0.41 to −0.04 for osteoarthritis (n = 7), −0.22 for knee pain (n = 1), and −0.56 for fibromyalgia (n = 1). Methodological quality was “critically low” for 17 reviews. Effectiveness tended to favor telemedicine for all secondary outcomes. Conclusions: Primary RCTs are required that compare telemedicine interventions with in-person delivery of the intervention (noninferiority trials), consider safety, assess videoconferencing, and combine different treatment approaches.
- 2 May 2024
- Published by SAGE Publications in Telemedicine and e-Health
- Vol. 30 (5) , 1221-1238
Open AccessTelemedicine for Patients with Musculoskeletal Pain Lacks High-Quality Evidence on Delivery Modes and Effectiveness: An Umbrella Review
Background: Musculoskeletal (MSK) pain is the leading cause of disability worldwide. Telemedicine is of growing importance, yet impacts on treatment efficacy remain unclear. Objective: This umbrella review (CRD42022298047) examined the effectiveness of telemedicine interventions on pain intensity, disability, psychological function, quality of life, self-efficacy, and adverse events in MSK pain. Methods: PubMed, SPORTDiscus, Cochrane Library, EMBASE, and CINAHL were searched from inception to August 9, 2022, for systematic reviews with meta-analysis, including telemedicine-delivered exercise, education, and psychological interventions, in randomized controlled trials (RCTs). AMSTAR-2 was implemented. Standardized mean differences (SMDs; negative favors telemedicine) were extracted as effect estimates. Results: Of 1,135 records, 20 reviews (RCTs: n = 97, participants: n = 15,872) were included. Pain intensity SMDs were −0.66 to 0.10 for mixed pain (estimates: n = 16), −0.64 to −0.01 for low-back pain (n = 9), −0.31 to −0.15 for osteoarthritis (n = 7), −0.29 for knee pain (n = 1), −0.66 to −0.58 for fibromyalgia (n = 2), −0.16 for back pain (n = 1), and −0.09 for rheumatic disorders (n = 1). Disability SMDs were −0.50 to 0.10 for mixed pain (n = 14), −0.39 to 0.00 for low-back pain (n = 8), −0.41 to −0.04 for osteoarthritis (n = 7), −0.22 for knee pain (n = 1), and −0.56 for fibromyalgia (n = 1). Methodological quality was “critically low” for 17 reviews. Effectiveness tended to favor telemedicine for all secondary outcomes. Conclusions: Primary RCTs are required that compare telemedicine interventions with in-person delivery of the intervention (noninferiority trials), consider safety, assess videoconferencing, and combine different treatment approaches.
- 24 February 2024
- Published by Wiley in European journal of pain
- Vol. 28 (5) , 857-858
Response to “Comment on ‘The importance of context (placebo effects) in conservative interventions for musculoskeletal pain: A systematic review and meta‐analysis of randomized controlled trials’ by Saueressig et al.”
- 24 February 2024
- Published by Wiley in European journal of pain
- Vol. 28 (5) , 857-858
Response to “Comment on ‘The importance of context (placebo effects) in conservative interventions for musculoskeletal pain: A systematic review and meta‐analysis of randomized controlled trials’ by Saueressig et al.”